• DIHYDROERGOTAMINE CHEMBL1732 FDA Approved

    Alternate Names:

    Dihydroergotamine
    SPECTRUM2_001188
    KBIO1_000592
    6190-39-2 (MESYLATE)
    NCGC00017400-06
    CHEBI:4562
    KBIOSS_001537
    CO-DERGOCRINE
    DIHYDROERGOTAMINUM [INN-LATIN]
    AGIT
    9,10-DIHYDROERGOTAMINE
    IDI1_000592
    ERGOTAMINE, DIHYDRO, METHANESULFONATE (SALT)
    NEOMIGRAN
    DIHIDROERGOTAMINA
    D07837
    DIHIDROERGOTAMINA [INN-SPANISH]
    DIIDROERGOTAMINA [DCIT]
    DET MS
    10321698
    MIGRANAL
    DIHYDROERGOTOXIN
    SEGLOR
    (5'ALPHA)-12'-HYDROXY-2'-METHYL-5'-(PHENYLMETHYL)ERGOTOMAN-3',6',18-TRIONE
    ERGOLOID MESYLATES (DIHYDROERGOTOXINE)
    11032-41-0
    DEHYDROERGOTAMINE
    LS-61979
    DIIDROERGOTAMINA
    (5'ALPHA)-5'-BENZYL-12'-HYDROXY-2'-METHYL-3',6',18-TRIOXOERGOTAMAN
    DIHYDERGOT
    SPECTRUM5_000905
    DIERGO
    CHEBI:658566
    DIHYDROERGOTAMINE (INN)
    C07798
    ERGOTOXINE, DIHYDRO-
    SPBIO_001235
    ERGOTAMINE, 9,10-DIHYDRO-
    CID517557
    ANGIONORM
    KBIO2_001537
    ERGOTONIN
    NINDS_000592
    KBIO3_001429
    AC1L1VEA
    ERGONT
    SPECTRUM3_000395
    ENDOPHLEBAN
    ERGOT ALKALOIDS, HYDROGENATED
    VERLADYN
    AMBOTZ511-12-6
    6420006
    CID10531
    ERGOLOID DIHYDROERGOTOXINE
    KBIO2_006673
    DIVK1C_000592
    AC1LAOVT
    DIHYDROERGOTAMINE METHANESULFONATE
    5'-BENZYL-12'-HYDROXY-2'-METHYL-3',6',18-TRIOXO-9,10-DIHYDROERGOTAMAN
    SPECTRUM_001057
    (10ALPHAH)-5'ALPHA-BENZYL-12'-HYDROXY-2'-METHYL-3',6',18-TRIOXO-9,10-DIHYDROERGOTAMAN
    NEOMIGRAN (TN)
    ERGOMIMET
    BRD-K72166146-066-02-1
    9,10-DIHYDRO-ERGOTAMINE
    KBIO2_004105
    ERGOTAMAN-3',6',18-TRIONE, 9,10-DIHYDRO-12'-HYDROXY-2'-METHYL-5'-(PHENYLMETHYL)-, (5'ALPHA,10ALPHA)-
    IKARAN
    DIHYDROERGOTAMINUM
    MORENA
    LOPAC0_000357
    TONOPRES
    ORSTANORM
    DERGOTAMINE
    LS-64563
    511-12-6
    BSPBIO_002209
    KBIOGR_001576
    DAP000852
    DIRGOTARL
    EINECS 208-123-3
    SPECTRUM4_000958
    BIDD:GT0120
    DB00320
    C33H37N5O5
    BRN 5720196
    DIHYDROERGOTOXINE
    9,10-DIHYDRO-12'-HYDROXY-2'-METHYL-5'-(PHENYLMETHYL)ERGOTOMAN-3',6',18-TRIONE
    D.H.E.
    UNII-436O5HM03C
    7-METHYL-4,6,6A,7,8,9-HEXAHYDRO-INDOLO[4,3-FG]QUINOLINE-9-CARBOXYLIC ACID (5-BENZYL-10B-HYDROXY-2-METHYL-3,6-DIOXO-OCTAHYDRO-OXAZOLO[3,2-A]PYRROLO[2,1-C]PYRAZIN-2-YL)-AMIDE
    2GM
    (2R,4R,7R)-N-[(1S,2S,4R,7S)-7-BENZYL-2-HYDROXY-4-METHYL-5,8-DIOXO-3-OXA-6,9-DIAZATRICYCLO[7.3.0.02,6]DODECAN-4-YL]-6-METHYL-6,11-DIAZATETRACYCLO[7.6.1.02,7.012,16]HEXADECA-1(16),9,12,14-TETRAENE-4-CARBOXAMIDE
    (2R,4R,7R)-N-[(1S,2S,4R,7S)-7-BENZYL-2-HYDROXY-4-METHYL-5,8-DIOXO-3-OXA-6,9-DIAZATRICYCLO[7.3.0.0;{2,6}]DODECAN-4-YL]-6-METHYL-6,11-DIAZATETRACYCLO[7.6.1.0;{2,7}.0;{12,16}]HEXADECA-1(16),9,12,14-TETRAENE-4-CARBOXAMIDE
    42124-EP2311829A1
    42124-EP2311808A1
    42124-EP2298765A1
    42124-EP2298764A1
    42124-EP2280008A2
    42124-EP2275420A1
    AN-45444
    NCGC00017400-08
    NCGC00017400-07
    CCG-204452
    TOX21_110821_1
    DAP000078
    BDBM50295557
    TOX21_110821
    ZINC3978005
    7-METHYL-4,6,6A,7,8,9,10,10A-OCTAHYDRO-INDOLO[4,3-FG]QUINOLINE-9-CARBOXYLIC ACID ((2R,5S,10BS)-5-BENZYL-10B-HYDROXY-2-METHYL-3,6-DIOXO-OCTAHYDRO-OXAZOLO[3,2-A]PYRROLO[2,1-C]PYRAZIN-2-YL)-AMIDE
    436O5HM03C
    LUZRJRNZXALNLM-JGRZULCMSA-N
    GTPL121
    SCHEMBL44931
    D.H.E. 45REG
    NCGC00017400-10
    DIHYDROERGOTAMIN
    MIGRANALREG
    CAS-511-12-6
    DSSTOX_GSID_45614
    DSSTOX_RID_81003
    DSSTOX_CID_25614
    NCGC00017400-05
    10531
    6190-39-2
    153817
    135650182
    121

    Drug Info:

    FDA Approval approved
    Drug Class Small Molecule
    Drug Indications antimigraine agent
    Year of Approval 1946
    Drug Class anti-migraine agents
    (2 More Sources)

    Publications:

  • Interaction Types:
    agonist

    Interaction Info:
    Trial Name MAP-0004, TEMPO Migraine,Levadex
    Novel drug target Established target
    Trial Name MT 300

    Publications:

  • Interaction Types:
    agonist

    Interaction Info:
    Trial Name MAP-0004, TEMPO Migraine,Levadex
    Novel drug target Established target
    Trial Name MT 300

    Publications:

  • Interaction Types:
    agonist

    Interaction Info:
    Specific Action of the Ligand Full agonist
    Endogenous Drug? False

    Publications:

  • Interaction Types:
    agonist

    Interaction Info:
    Specific Action of the Ligand Full agonist
    Endogenous Drug? False

    Publications:

  • Interaction Types:
    antagonist

    Interaction Info:
    Specific Action of the Ligand Antagonist
    Endogenous Drug? False

    Publications:

  • Interaction Types:
    agonist

    Interaction Info:

    Publications:

    • Version: 01-August-2011

    Alternate Names:
    DIHYDROERGOTAMINE Primary Drug Name

    Drug Info:
    Drug Class anti-migraine agents
    Year of Approval 1946

    Publications:

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications antimigraine agent
    Drug Class Small Molecule
    FDA Approval approved

    Publications:

    • Version: 4.3.02 (25-August-2011)

    Alternate Names:
    UNII-436O5HM03C Drug Synonym
    D.H.E. Drug Synonym
    9,10-DIHYDRO-12'-HYDROXY-2'-METHYL-5'-(PHENYLMETHYL)ERGOTOMAN-3',6',18-TRIONE Drug Synonym

    Drug Info:

    Publications:

    • Version: 09-Feb-2016

    Alternate Names:
    DIHYDERGOT Drug Synonym
    DIHYDROERGOTAMINE pubchem_primary_name
    10531 PubChem CID

    Drug Info:

    Publications:

    • Version: 4.3.02 (25-August-2011)

    Alternate Names:
    SPECTRUM3_000395 Drug Synonym
    DIHIDROERGOTAMINA [INN-SPANISH] Drug Synonym
    SEGLOR Drug Synonym

    Drug Info:

    Publications:

    • Version: 27-September-2017

    Alternate Names:
    DIHYDROERGOTAMINE GuideToPharmacology Ligand Name
    135650182 PubChem Drug SID

    Drug Info:

    Publications: